Satu Tiainen

Kuopio, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer.

The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer.

Journal: Drugs - real world outcomes

Published: June 01, 2026

Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors.

Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors.

Journal: Cancer immunology, immunotherapy : CII

Published: March 01, 2026

Comprehensive cancer care in the Nordic countries; Strengths, opportunities and improvement profiles.

Comprehensive cancer care in the Nordic countries; Strengths, opportunities and improvement profiles.

Journal: Journal of cancer policy

Published: January 31, 2026

Distinct roles of WHO Score, CCI, and CFS in prognosis and treatment decisions for non-small cell lung cancer: A retrospective real-world study.

Distinct roles of WHO Score, CCI, and CFS in prognosis and treatment decisions for non-small cell lung cancer: A retrospective real-world study.

Journal: Cancer treatment and research communications

Published: October 02, 2025

Clinicopathological characteristics of patients with inoperable non-small cell lung cancer harboring circulating NRF2 pathway mutations.

Clinicopathological characteristics of patients with inoperable non-small cell lung cancer harboring circulating NRF2 pathway mutations.

Journal: The Journal of pathology

Published: July 09, 2025

Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: April 26, 2025

Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events.

Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events.

Journal: Immunotherapy

Published: April 23, 2025

Outcome of lung cancer surgery and proportion of lung cancer patients eligible for surgery in five Finnish hospitals in 2018, real world study.

Outcome of lung cancer surgery and proportion of lung cancer patients eligible for surgery in five Finnish hospitals in 2018, real world study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 18, 2025

High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer.

High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer.

Journal: Cancers

Published: December 28, 2023

Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study.

Trends in cost of treatment of lung cancer patients in 2014-2019 in Finland - a descriptive register study.

Journal: Acta oncologica (Stockholm, Sweden)

Published: July 17, 2023

A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors.

A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors.

Journal: BMC cancer

Published: June 16, 2023

The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer.

The prognostic and predictive role of tumor-infiltrating lymphocytes (FoxP3 + and CD8 +) and tumor-associated macrophages in early HER2 + breast cancer.

Journal: Breast cancer research and treatment

Published: March 30, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026